PL4111865T3 - Formulacja przeciwbakteryjna mieszaniny bakteriofagów do stosowania w zapobieganiu lub leczeniu chorób powodowanych przez Salmonella spp. - Google Patents
Formulacja przeciwbakteryjna mieszaniny bakteriofagów do stosowania w zapobieganiu lub leczeniu chorób powodowanych przez Salmonella spp.Info
- Publication number
- PL4111865T3 PL4111865T3 PL21870473.2T PL21870473T PL4111865T3 PL 4111865 T3 PL4111865 T3 PL 4111865T3 PL 21870473 T PL21870473 T PL 21870473T PL 4111865 T3 PL4111865 T3 PL 4111865T3
- Authority
- PL
- Poland
- Prior art keywords
- bacteriophages
- preventing
- mixture
- diseases caused
- treating diseases
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 2
- 241000607142 Salmonella Species 0.000 title 1
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 241001515965 unidentified phage Species 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N63/00—Biocides, pest repellants or attractants, or plant growth regulators containing microorganisms, viruses, microbial fungi, animals or substances produced by, or obtained from, microorganisms, viruses, microbial fungi or animals, e.g. enzymes or fermentates
- A01N63/40—Viruses, e.g. bacteriophages
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P1/00—Disinfectants; Antimicrobial compounds or mixtures thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10111—Myoviridae
- C12N2795/10132—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2795/00—Bacteriophages
- C12N2795/00011—Details
- C12N2795/10011—Details dsDNA Bacteriophages
- C12N2795/10311—Siphoviridae
- C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Microbiology (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Agronomy & Crop Science (AREA)
- Dentistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CL2021/050044 WO2022241579A1 (es) | 2021-05-19 | 2021-05-19 | Formulación antibacteriana compuesta de una mezcla de bacteriófagos; uso y método para prevenir o tratar enfermedades causadas por salmonella spp. en animales de crianza mediante la administración oral de la formulación |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL4111865T3 true PL4111865T3 (pl) | 2023-07-10 |
Family
ID=84140307
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL21870473.2T PL4111865T3 (pl) | 2021-05-19 | 2021-05-19 | Formulacja przeciwbakteryjna mieszaniny bakteriofagów do stosowania w zapobieganiu lub leczeniu chorób powodowanych przez Salmonella spp. |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US11826391B2 (pl) |
| EP (1) | EP4111865B1 (pl) |
| PL (1) | PL4111865T3 (pl) |
| WO (1) | WO2022241579A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024042387A1 (en) * | 2022-08-22 | 2024-02-29 | Phagelab Chile Spa | Bacteriophage cocktail with broad-spectrum lytic activity against salmonella serovars |
| CN118834780B (zh) * | 2024-06-11 | 2025-11-18 | 江苏省家禽科学研究所 | 一种丙酸钠抑制沙门氏菌毒力因子的方法及应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR101151516B1 (ko) | 2008-12-24 | 2012-05-30 | 씨제이제일제당 (주) | 신규한 박테리오파지 및 이를 포함하는 항균 조성물 |
| EP2550870A1 (en) | 2011-07-27 | 2013-01-30 | Universitat Autònoma De Barcelona | Novel salmonella bacteriophage compositions and uses thereof |
| JP6112961B2 (ja) | 2013-05-09 | 2017-04-12 | サラヤ株式会社 | サルモネラ属菌に対して溶菌性を示す新規バクテリオファージ、及びそれを含有する組成物 |
| US10576114B2 (en) | 2015-11-25 | 2020-03-03 | Universidad De Los Andes | Composition comprising bacteriophages for reducing, eliminating and/or preventing Salmonella enteritidis, Salmonella typhimurium and Salmonella paratyphi B |
| CN108359644B (zh) | 2018-02-07 | 2019-08-02 | 青岛诺安百特生物技术有限公司 | 一种宽谱沙门氏菌噬菌体及其应用 |
-
2021
- 2021-05-19 PL PL21870473.2T patent/PL4111865T3/pl unknown
- 2021-05-19 US US17/764,112 patent/US11826391B2/en active Active
- 2021-05-19 WO PCT/CL2021/050044 patent/WO2022241579A1/es not_active Ceased
- 2021-05-19 EP EP21870473.2A patent/EP4111865B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20230270801A1 (en) | 2023-08-31 |
| US11826391B2 (en) | 2023-11-28 |
| EP4111865A1 (en) | 2023-01-04 |
| EP4111865B1 (en) | 2023-05-03 |
| WO2022241579A1 (es) | 2022-11-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2020011250A (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret. | |
| PH12017500852A1 (en) | Combination therapy for treatment of resistant bacterial infections | |
| MX2017012545A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| MX2016009251A (es) | Derivados de 7-oxo-1, 6-diazabiciclo [3.2.1] octano y su uso como agentes antibacterianos. | |
| CR20190224A (es) | Compuestos de pirazolo[1,5-a]piridina sustituidos como inhibidores de la quinasa ret | |
| PH12016501577A1 (en) | Monobactam organic compounds for the treatment of bacterial infections | |
| ZA202002093B (en) | Antibacterial compounds | |
| MY209256A (en) | Compounds affecting pigment production and use thereof for treatment of bacterial diseases | |
| IL275795A (en) | Medical bacteriophage preparations for the treatment of staphylococcus infection | |
| MX2017012535A (es) | Compuestos hetorociclicos novedosos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| MY205173A (en) | Use of benzenesulfonamide derivatives or a pharmaceutically acceptable salt thereof for treatment of adenoid cystic carcinoma | |
| BR112021025732A2 (pt) | Inibidores macrocíclicos de mcl-1 | |
| MX2019011908A (es) | Macrociclos de peptidos anti-bacterianos y uso de los mismos. | |
| MX2017014080A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| IL307344B2 (en) | Lactavicin compounds, their preparation and use as antibacterial agents | |
| NZ754706A (en) | Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus | |
| MX2018001022A (es) | Antibiotico aminoglucosido novedoso efectivo contra bacterias resistentes a multiples farmacos. | |
| EP4111865A4 (en) | Antibacterial formulation made of a mixture of bacteriophages, use thereof, and method for preventing or treating diseases caused by salmonella spp. in breeding animals, by orally administering the formulation | |
| MX2017012539A (es) | Compuestos heterociclicos y su uso en la prevencion o tratamiento de las infecciones bacterianas. | |
| BR112016018048A2 (pt) | Método para o tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina no tratamento ou prevenção de uma infecção bacteriana, uso de um inibidor de topoisomerase tipo ii bacteriana em combinação com uma polimixina ou derivado de polimixina na preparação de um medicamento para o tratamento ou prevenção de uma infecção bacteriana, método para melhorar a atividade antibacteriana de um inibidor de topoisomerase tipo ii bacteriana, método para melhorar a eficácia bactericida de um inibidor de topoisomerase tipo ii bacteriana, composição, agente antibacteriano, processo, e, composto | |
| ZA202110692B (en) | Compounds and methods of use thereof as antibacterial agents | |
| SI4072532T1 (sl) | Dozirna oblika za uporabo v zdravljenju ali preprečevanju bolezni | |
| AR110913A1 (es) | Compuesto aminoglucósido y su uso para prevenir o tratar enfermedades infecciosas | |
| PL3694505T3 (pl) | Związek i kompozycja do stosowania w leczeniu profilaktycznym i/lub terapeutycznym chorób ośrodkowego układu nerwowego charakteryzujących się spadkiem plastyczności neuronalnej, w szczególności charakteryzujących się spadkiem plastyczności synaptycznej | |
| MX2022006180A (es) | Derivados macrociclicos de sulfonilo como inhibidores de mcl-1. |